Annual Accounts Payable
$9.03 M
+$1.99 M+28.26%
December 31, 2024
Summary
- As of March 10, 2025, AKRO annual accounts payable is $9.03 million, with the most recent change of +$1.99 million (+28.26%) on December 31, 2024.
- During the last 3 years, AKRO annual accounts payable has risen by +$2.32 million (+34.61%).
- AKRO annual accounts payable is now at all-time high.
Performance
AKRO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$9.03 M
-$16.20 M-64.21%
December 31, 2024
Summary
- As of March 10, 2025, AKRO quarterly accounts payable is $9.03 million, with the most recent change of -$16.20 million (-64.21%) on December 31, 2024.
- Over the past year, AKRO quarterly accounts payable has dropped by -$16.20 million (-64.21%).
- AKRO quarterly accounts payable is now -64.21% below its all-time high of $25.22 million, reached on September 30, 2024.
Performance
AKRO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AKRO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.3% | -64.2% |
| 3 y3 years | +34.6% | +34.6% |
| 5 y5 years | +853.2% | +853.2% |
AKRO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.6% | -64.2% | +102.8% |
| 5 y | 5-year | at high | +853.2% | -64.2% | +853.2% |
| alltime | all time | at high | >+9999.0% | -64.2% | +9606.5% |
Akero Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $9.03 M(+28.3%) | $9.03 M(-64.2%) |
| Sep 2024 | - | $25.22 M(+73.1%) |
| Jun 2024 | - | $14.57 M(+5.7%) |
| Mar 2024 | - | $13.78 M(+95.8%) |
| Dec 2023 | $7.04 M(-11.7%) | $7.04 M(-38.6%) |
| Sep 2023 | - | $11.45 M(+13.2%) |
| Jun 2023 | - | $10.12 M(+43.0%) |
| Mar 2023 | - | $7.08 M(-11.1%) |
| Dec 2022 | $7.97 M(+18.8%) | $7.97 M(+32.6%) |
| Sep 2022 | - | $6.01 M(-12.6%) |
| Jun 2022 | - | $6.88 M(+54.5%) |
| Mar 2022 | - | $4.45 M(-33.6%) |
| Dec 2021 | $6.71 M | $6.71 M(-1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $6.78 M(+194.1%) |
| Jun 2021 | - | $2.31 M(-49.9%) |
| Mar 2021 | - | $4.61 M(+34.3%) |
| Dec 2020 | $3.43 M(+262.0%) | $3.43 M(-26.1%) |
| Sep 2020 | - | $4.64 M(+82.8%) |
| Jun 2020 | - | $2.54 M(+65.2%) |
| Mar 2020 | - | $1.53 M(+62.1%) |
| Dec 2019 | $947.00 K(-31.0%) | $947.00 K(+918.3%) |
| Sep 2019 | - | $93.00 K(-97.1%) |
| Jun 2019 | - | $3.25 M(+241.2%) |
| Mar 2019 | - | $952.00 K(-30.7%) |
| Dec 2018 | $1.37 M(+2188.3%) | $1.37 M |
| Dec 2017 | $60.00 K | - |
FAQ
- What is Akero Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Akero Therapeutics?
- What is Akero Therapeutics annual accounts payable year-on-year change?
- What is Akero Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Akero Therapeutics?
- What is Akero Therapeutics quarterly accounts payable year-on-year change?
What is Akero Therapeutics annual accounts payable?
The current annual accounts payable of AKRO is $9.03 M
What is the all time high annual accounts payable for Akero Therapeutics?
Akero Therapeutics all-time high annual accounts payable is $9.03 M
What is Akero Therapeutics annual accounts payable year-on-year change?
Over the past year, AKRO annual accounts payable has changed by +$1.99 M (+28.26%)
What is Akero Therapeutics quarterly accounts payable?
The current quarterly accounts payable of AKRO is $9.03 M
What is the all time high quarterly accounts payable for Akero Therapeutics?
Akero Therapeutics all-time high quarterly accounts payable is $25.22 M
What is Akero Therapeutics quarterly accounts payable year-on-year change?
Over the past year, AKRO quarterly accounts payable has changed by -$16.20 M (-64.21%)